Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Talat Imran

CEO at Rani Therapeutics Holdings, Inc. (RANI)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$3K
Total bought / sold$25K / $11K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 21SEC RANIRani Therapeutics Holdings, Inc. Sell 8,014486,737 held (−2%) $1.41 $11K -43.3%
Jul 21SEC RANIRani Therapeutics Holdings, Inc. Buy 35,000469,736 held (+8%) $0.72 $25K +11.0%
  • Buy

    CEO Talat Imran bought $25K of RANI at $0.72 — first open-market purchase in our records.